Practice of CYP450 genotyping and phenotyping in children in a real-life setting
Pharmacokinetics varies widely between children. Many factors play an important role in this
variability, such as ontogeny, pharmacogenetics, gender, comorbidities, and drug-drug …
variability, such as ontogeny, pharmacogenetics, gender, comorbidities, and drug-drug …
Modern approaches for the phenotyping of cytochrome P450 enzymes in children
G Magliocco, Y Daali - Expert review of clinical pharmacology, 2020 - Taylor & Francis
From birth, children may need to take medication for acute or chronic diseases. Antibiotics,
anti-asthmatic drugs, antihistamines, analgesics, gastrointestinal drugs and attention …
anti-asthmatic drugs, antihistamines, analgesics, gastrointestinal drugs and attention …
Challenges for drug studies in children: CYP3A phenotyping as example
SN de Wildt, S Ito, G Koren - Drug discovery today, 2009 - Elsevier
A paucity of data exists on the disposition and effect of drugs in young children. This
information gap can be reduced by elucidating developmental principles of absorption …
information gap can be reduced by elucidating developmental principles of absorption …
Clinical pharmacogenetics of cytochrome P450-associated drugs in children
I Aka, CJ Bernal, R Carroll, A Maxwell-Horn… - Journal of personalized …, 2017 - mdpi.com
Cytochrome P450 (CYP) enzymes are commonly involved in drug metabolism, and genetic
variation in the genes encoding CYPs are associated with variable drug response. While …
variation in the genes encoding CYPs are associated with variable drug response. While …
Frequency of common CYP3A5 gene variants in healthy Polish newborn infants
G Adler, B Łoniewska, M Parczewski, A Kordek… - Pharmacological …, 2009 - Springer
Cytochrome P450 monooxygenases catalyze the metabolism of approximately 40-60% of
widely used drugs with a A6986G CYP3A5 polymorphism determining expresser (A6986 …
widely used drugs with a A6986G CYP3A5 polymorphism determining expresser (A6986 …
Cytochrome P450: genotype to phenotype
RH Waring - Xenobiotica, 2020 - Taylor & Francis
The cytochromes P450 comprise a family of enzymes that are responsible for around three-
quarters of all drug metabolism reactions that occur in human populations. Many isoforms of …
quarters of all drug metabolism reactions that occur in human populations. Many isoforms of …
Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment
J Brockmöller, J Kirchheiner, C Meisel, I Roots - Pharmacy Today, 2004 - Taylor & Francis
The current use and future perspectives of molecular genetic characterisation of cytochrome
P450 enzymes (CYP) for drug development and drug treatment are summarised. CYP …
P450 enzymes (CYP) for drug development and drug treatment are summarised. CYP …
Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences
A Rodrigues, TH Rushmore - Current drug metabolism, 2002 - ingentaconnect.com
Members of the human cytochrome P450 (CYP) superfamily play a role in the metabolism of
many drugs and several of them, CYP2D6, CYP2C9 and CYP2C19, have been shown to be …
many drugs and several of them, CYP2D6, CYP2C9 and CYP2C19, have been shown to be …
Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology
D Fanni, R Ambu, C Gerosa… - International journal …, 2014 - journals.sagepub.com
The cytochrome P450 superfamily (CYP450) in humans is formed by 57 functional
monooxygenases critical for the metabolism of numerous endogenous and exogenous …
monooxygenases critical for the metabolism of numerous endogenous and exogenous …
The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects
SC Sim, M Ingelman-Sundberg - Human genomics, 2010 - Springer
Pharmacogenetics affects both pharmacokinetics and pharmacodynamics, thereby
influencing an individual's response to drugs, both in terms of response and adverse …
influencing an individual's response to drugs, both in terms of response and adverse …